Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: Identification of three novel mutations in the APOA1 gene

Journal of Molecular Diagnostics

Volumn 11, Issue 3, 2009, Pages 257-262

  Eriksson, Magdalena ^a   Schönland, Stefan ^b   Yumlu, Saniye ^a   Hegenbart, Ute ^b   Von Hutten, Hanna ^a   Gioeva, Zarina ^a   Lohse, Peter ^c   Büttner, Janine ^a   Schmidt, Hartmut ^d   Röcken, Christoph ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; APOLIPOPROTEIN A1; CONGO RED; APOA1 PROTEIN, HUMAN;

ADULT; AGED; APOLIPOPROTEIN A1 GENE; ARTICLE; CLINICAL ARTICLE; CODON; FAMILIAL AMYLOIDOSIS; FEMALE; FRAMESHIFT MUTATION; GENE; GENE IDENTIFICATION; GENE MUTATION; GENETIC VARIABILITY; HEART AMYLOIDOSIS; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; KIDNEY AMYLOIDOSIS; LARYNX; LIVER; MALE; ORGAN DISTRIBUTION; OVARY; PELVIS LYMPH NODE; SEQUENCE ANALYSIS; SMALL INTESTINE; STAINING; UTERUS; BIOPSY; CASE REPORT; CHEMISTRY; DNA SEQUENCE; GENETICS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTATION; PATHOLOGY; PROTEIN SECONDARY STRUCTURE;

MALUS X DOMESTICA;

ADULT; AGED; AMYLOIDOSIS, FAMILIAL; APOLIPOPROTEIN A-I; BIOPSY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; PROTEIN STRUCTURE, SECONDARY; SEQUENCE ANALYSIS, DNA;

EID: 67149119593     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2009.080161     Document Type: Article

References (33)

1. Westermark P: Aspects on human amyloid forms and their fibril polypeptides. FEBS J 2005, 272:5942-5949
2. Benson MD, Kincaid JC: The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 2007, 36:411-423
3. Mucchiano GI, Jonasson L, Häggqvist B, Einarsson E, Westermark P: Apolipoprotein A-I-derived amyloid in atherosclerosis. Its association with plasma levels of apolipoprotein A-I and cholesterol Am J Clin Pathol 2001, 115:298-303
4. Obici L, Franceschini G, Calabresi L, Giorgetti S, Stoppini M, Merlini G, Bellotti V: Structure, function and amyloidogenic propensity of apolipoprotein A-I. Amyloid 2006, 13:191-205
5. Sorci-Thomas MG, Thomas MJ: The effects of altered apolipoprotein A-I structure on plasma HDL concentration. Trends Cardiovasc Med 2002, 12:121-128
6. Karathanasis SK, Zannis VI, Breslow JL: Isolation and characterization of the human apolipoprotein A-I gene. Proc Natl Acad Sci USA 1983, 80:6147-6151
7. van Allen MW, Frohlich JA, Davis JR: Inherited predisposition to generalized amyloidosis. Clinical and pathological study of a family with neuropathy, nephropathy, and peptic ulcer. Neurology 1969, 19:10-25
8. Nichols WC, Gregg RE, Brewer HB, Jr., Benson MD: A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. Genomics 1990, 8:318-323
9. Booth DR, Tan SY, Booth SE, Hsuan JJ, Totty NF, Nguyen O, Hutton T, Vigushin DM, Tennent GA, Hutchinson WL: A new apolipoprotein Al variant, Trp50Arg, causes hereditary amyloidosis. QJM 1995;88: 695-702
10. Soutar AK, Hawkins PN, Vigushin DM, Tennent GA, Booth SE, Hutton T, Nguyen O, Totty NF, Feest TG, Hsuan JJ: Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis. Proc Natl Acad Sci USA 1992;89:7389-7393
11. Murphy CL, Wang S, Weaver K, Gertz MA, Weiss DT, Solomon A: Renal apolipoprotein A-I amyloidosis associated with a novel mutant Leu64Pro. Am J Kidney Dis 2004, 44:1103-1109
12. Booth DR, Tan SY, Booth SE, Tennent GA, Hutchinson WL, Hsuan JJ, Totty NF, Truong O, Soutar AK, Hawkins PN, Bruguera M, Caballeria J, Sole M, Campistol JM, Pepys MB: Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene. J Clin Invest 1996, 97:2714-2721
13. Persey MR, Booth DR, Booth SE, van Zyl-Smit R, Adams BK, Fattaar AB, Tennent GA, Hawkins PN, Pepys MB: Hereditary nephropathic systemic amyloidosis caused by a novel variant apolipoprotein A-I. Kidney Int 1998, 53:276-281
14. Coriu D, Dispenzieri A, Stevens FJ, Murphy CL, Wang S, Weiss DT, Solomon A: Hepatic amyloidosis resulting from deposition of the apolipoprotein A-I variant Leu75Pro. Amyloid 2003, 10:215-223
15. Obici L, Palladini G, Giorgetti S, Bellotti V, Gregorini G, Arbustini E, Verga L, Marciano S, Donadei S, Perfetti V, Calabresi L, Bergonzi C, Scolari F, Merlini G: Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families. Gastroenterology 2004, 126:1416-1422
16. Hamidi AL, Liepnieks JJ, Hamidi AK, Uemichi T, Moulin G, Desjoyaux E, Loire R, Delpech M, Grateau G, Benson MD: Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1. Am J Pathol 1999, 154:221-227
17. Amarzguioui M, Mucchiano G, Häggqvist B, Westermark P, Kavlie A, Sletten K, Prydz H: Extensive intimal apolipoprotein A1-derived amyloid deposits in a patient with an apolipoprotein A1 mutation. Biochem Biophys Res Commun 1998, 242:534-539
18. Hamidi AK, Liepnieks JJ, Nakamura M, Parker F, Benson MD: A novel apolipoprotein A-1 variant. Arg173Pro, associated with cardiac and cutaneous amyloidosis. Biochem Biophys Res Commun 1999, 257:584-588
19. Obici L, Bellotti V, Mangione P, Stoppini M, Arbustini E, Verga L, Zorzoli I, Anesi E, Zanotti G, Campana C, Vigano M, Merlini G: The new apolipoprotein A-I variant Leu(174) → Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide. Am J Pathol 1999, 155:695-702
20. Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, Pepys MB, Hawkins PN: Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 2002, 346:1786-1791
21. de Sousa MM, Vital C, Ostler D, Fernandes R, Pouget-Abadie J, Carles D, Saraiva MJ: Apolipoprotein AI and transthyretin as components of amyloid fibrils in a kindred with apoAI Leu178His amyloidosis. Am J Pathol 2000, 156:1911-1917
22. Gregorini G, Izzi C, Obici L, Tardanico R, Röcken C, Viola BF, Capistrano M, Donadei S, Biasi L, Scalvini T, Merlini G, Scolari F: Renal apolipoprotein A-I amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritis. J Am Soc Nephrol 2005, 16:3680-3686
23. Bohne S, Sletten K, Menard R, Bühling F, Vöckler S, Wrenger E, Roessner A, Röcken C: Cleavage of AL amyloid proteins and AL amyloid deposits by cathepsins B, K, and L. J Pathol 2004, 203:528-537
24. Kuci H, Ebert MP, Röcken C: Anti-lambda-light chain-peptide antibodies are suitable for the immunohistochemical classification of AL amyloid. Histol Histopathol 2007, 22:379-387
25. Hoshii Y, Setoguchi M, Iwata T, Ueda J, Cui D, Kawano H, Gondo T, Takahashi M, Ishihara T: Useful polyclonal antibodies against synthetic peptides corresponding to immunoglobulin light chain constant region for immunohistochemical detection of immunoglobulin light chain amyloidosis. Pathol Int 2001, 51:264-270
26. Ostertag. Familiäre Amyloid-Erkrankung. Z Mensch Vererb Konstitutionsl 1950, 30:105-115
27. Andrade C: A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952, 75:408-427
28. Caballeria J, Bruguera M, Sole M, Campistol JM, Rodes J: Hepatic familial amyloidosis caused by a new mutation in the apolipoprotein AI gene: clinical and pathological features. Am J Gastroenterol 2001, 96:1872-1876
29. Eriksson M, Schönland S, Bergner R, Hegenbart U, Lohse P, Schmidt H, Röcken C: Three German fibrinogen Aalpha-chain amyloidosis patients with the p.Glu526Val mutation. Virchows Arch 2008, 453:25-31
30. Eriksson M, Büttner J, Todorov T, Yumlu S, Schönland S, Hegenbart U, Kristen AV, Dengler T, Lohse P, Helmke B, Schmidt H, Röcken C: Prevalence of germline mutations in the TTR gene in a consecutive series of surgical pathology specimens with ATTR amyloid. Am J Surg Pathol 2009, 33:58-65
31. Solomon A, Murphy CL, Kestler D, Coriu D, Weiss DT, Makovitzky J, Westermark P: Amyloid contained in the knee joint meniscus is formed from apolipoprotein A-I. Arthritis Rheum 2006, 54:3545-3550
32. Nichols WC, Dwulet FE, Liepnieks J, Benson MD: Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. Biochem Biophys Res Commun 1988, 156:762-768
33. Röcken C, Menard R, Bühling F, Vöckler S, Raynes J, Stix B, Krüger S, Roessner A, Kähne T: Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation. Ann Rheum Dis 2005, 64:808-815